- Home
- ON vs DGX Comparison
ON vs DGX Comparison
Compare ON & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ON
- DGX
- Stock Information
- Founded
- ON 1992
- DGX 1967
- Country
- ON United States
- DGX United States
- Employees
- ON N/A
- DGX N/A
- Industry
- ON Semiconductors
- DGX Medical Specialities
- Sector
- ON Technology
- DGX Health Care
- Exchange
- ON Nasdaq
- DGX Nasdaq
- Market Cap
- ON 20.4B
- DGX 20.5B
- IPO Year
- ON 2000
- DGX 1996
- Fundamental
- Price
- ON $51.80
- DGX $178.28
- Analyst Decision
- ON Buy
- DGX Buy
- Analyst Count
- ON 23
- DGX 15
- Target Price
- ON $57.43
- DGX $194.07
- AVG Volume (30 Days)
- ON 9.1M
- DGX 1.2M
- Earning Date
- ON 11-03-2025
- DGX 10-21-2025
- Dividend Yield
- ON N/A
- DGX 1.78%
- EPS Growth
- ON N/A
- DGX 14.49
- EPS
- ON 1.09
- DGX 8.51
- Revenue
- ON $6,398,800,000.00
- DGX $10,850,000,000.00
- Revenue This Year
- ON N/A
- DGX $11.17
- Revenue Next Year
- ON $6.22
- DGX $3.48
- P/E Ratio
- ON $47.62
- DGX $20.94
- Revenue Growth
- ON N/A
- DGX 13.74
- 52 Week Low
- ON $31.04
- DGX $148.70
- 52 Week High
- ON $76.06
- DGX $197.55
- Technical
- Relative Strength Index (RSI)
- ON 51.78
- DGX 40.34
- Support Level
- ON $50.23
- DGX $179.53
- Resistance Level
- ON $53.39
- DGX $184.73
- Average True Range (ATR)
- ON 2.40
- DGX 3.99
- MACD
- ON 0.12
- DGX -0.82
- Stochastic Oscillator
- ON 58.39
- DGX 5.45
About ON ON Semiconductor Corporation
Onsemi is a supplier of power semiconductors and sensors focused on the automotive and industrial markets. Onsemi is the second-largest power chipmaker in the world and the largest supplier of image sensors to the automotive market. While the firm used to be highly vertically integrated, it now pursues a hybrid manufacturing strategy for flexible capacity. Onsemi is pivoting to focus on emerging applications like electric vehicles, autonomous vehicles, industrial automation, and renewable energy.
About DGX Quest Diagnostics Incorporated
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.